Common Contracts
17 similar Credit and Security Agreement contracts by Ocular Therapeutix, Inc, Mannkind Corp, STRATA Skin Sciences, Inc., others
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • November 7th, 2023 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Delaware
CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of August 2, 2023 (the “Closing Date”) by and among Barings Finance LLC, a Delaware limited liability company (“Barings”), as administrative agent (“Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and OCULAR THERAPEUTIX, INC., a Delaware corporation (“Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders.
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • October 4th, 2021 • STRATA Skin Sciences, Inc. • Surgical & medical instruments & apparatus • New York
This CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of September 30, 2021 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent, the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and STRATA SKIN SCIENCES, INC., a Delaware corporation (together with each of its subsidiaries that hereafter becomes a party to this Agreement, the “Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
FOURTH AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • June 4th, 2021 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Maryland
THIS FOURTH AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of June 4, 2021 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent (together with its successors and assigns, “Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and OCULAR THERAPEUTIX, INC., a Delaware corporation (“Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders.
AMENDMENT NO. 7 TO CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • April 26th, 2021 • Mannkind Corp • Pharmaceutical preparations • New York
This AMENDMENT NO. 7 TO CREDIT AND SECURITY AGREEMENT (this “Agreement”) is made as of this 22nd day of April, 2021, by and among MANNKIND CORPORATION, a Delaware corporation (“MannKind”), MANNKIND LLC, a Delaware limited liability company (“MannKind LLC”), QRUMPHARMA, INC., a Delaware corporation (“QP”, and, QP, together with MannKind and MannKind LLC, each a “Borrower” and collectively, the “Borrowers”), MIDCAP FINANCIAL TRUST, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • March 22nd, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of September 18, 2019 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent, the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and RECURSION PHARMACEUTICALS, INC., a Delaware corporation as Borrower (“Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENT dated as of September 27, 2019 by and among RIGEL PHARMACEUTICALS, INC., as a Borrower and any additional borrower that hereafter becomes party hereto, and MIDCAP FINANCIAL TRUST, as Agent and as a Lender, and THE...Credit and Security Agreement • November 5th, 2019 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of September 27, 2019 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent, the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), RIGEL PHARMACEUTICALS, INC., a Delaware corporation (“Rigel”), and the other entities from time to time party to this Agreement as borrowers (collectively in the singular, “Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENT dated as of August 6, 2019 by and among MANNKIND CORPORATION, MANNKIND LLC, each as a Borrower and any additional borrower that hereafter becomes party hereto, and MIDCAP FINANCIAL TRUST, as Agent and as a Lender, and THE...Credit and Security Agreement • August 7th, 2019 • Mannkind Corp • Pharmaceutical preparations • New York
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of August 6, 2019 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent, the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), MANNKIND CORPORATION, a Delaware corporation (“MannKind”), MANNKIND LLC, a Delaware limited liability company (“MannKind LLC”) and the other entities from time to time party to this Agreement as borrowers (collectively in the singular, “Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • July 13th, 2018 • BioNano Genomics, Inc • Laboratory analytical instruments • New York
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of June 29, 2018 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent, the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and BIONANO GENOMICS, INC., a Delaware corporation (“BioNano”) and the other entities from time to time party to this Agreement as borrowers, provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • May 6th, 2016 • Sancilio Pharmaceuticals Company, Inc. • Pharmaceutical preparations • Maryland
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of February 1, 2016 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent (“Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and SANCILIO PHARMACEUTICALS COMPANY, INC., a Delaware corporation (“Parent”) and the other entities shown as signatories hereto as a Borrower (collectively in the singular, “Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • January 5th, 2016 • STRATA Skin Sciences, Inc. • Surgical & medical instruments & apparatus • Maryland
THIS CREDIT AND SECURITY AGREEMENT (this "Agreement"), dated as of December 30, 2015 (the "Closing Date") by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust ("MidCap"), as administrative agent ("Agent"), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a "Lender", and collectively the "Lenders"), and MELA SCIENCES, INC., a Delaware corporation (as such name may be changed after the date hereof to Strata Skin Sciences, Inc.) (together with each of its subsidiaries that hereafter becomes a party to this Agreement, the "Borrower"), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • August 6th, 2015 • Sarepta Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of June 26, 2015 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent (“Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and SAREPTA THERAPEUTICS, INC., a Delaware corporation (“Sarepta”), and the other entities shown as signatories hereto as a Borrower (collectively in the singular, “Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • July 17th, 2014 • ZS Pharma, Inc. • Pharmaceutical preparations • Maryland
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of July 14, 2014 (the “Closing Date”) by and among MIDCAP FINANCIAL SBIC, LP, a Delaware limited partnership (“MidCap”), as administrative agent (“Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and ZS PHARMA, INC., a Delaware corporation (“Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • June 20th, 2014 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Delaware
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of April 17, 2014 (the “Closing Date”) by and among MIDCAP FINANCIAL SBIC, LP, a Delaware limited partnership (“MidCap”), as administrative agent (“Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and OCULAR THERAPEUTIX, INC., a Delaware corporation (“Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • April 29th, 2014 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Delaware
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of April 17, 2014 (the “Closing Date”) by and among MIDCAP FINANCIAL SBIC, LP, a Delaware limited partnership (“MidCap”), as administrative agent (“Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and OCULAR THERAPEUTIX, INC., a Delaware corporation (“Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
Credit and Security Agreement CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • December 30th, 2013 • Amicus Therapeutics Inc • Pharmaceutical preparations • Maryland
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of December 27, 2013 (the “Closing Date”) by and among MIDCAP FUNDING III, LLC, a Delaware limited liability company, as administrative agent (“Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), AMICUS THERAPEUTICS, INC., a Delaware corporation (“Parent”), and the other entities shown as signatories hereto as a Borrower (together with Parent, individually each a, and collectively in the singular as the context may require, “Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • April 5th, 2013 • Anthera Pharmaceuticals Inc • Pharmaceutical preparations • Maryland
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of April 3, 2013 (the “Closing Date”) by and among MIDCAP FINANCIAL SBIC, LP, a Delaware limited partnership (“MidCap”), as administrative agent (“Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and ANTHERA PHARMACEUTICALS, INC., a Delaware corporation, and the other entities from time to time shown as signatories hereto as a Borrower (collectively in the singular, “Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • February 20th, 2013 • Cytomedix Inc • Surgical & medical instruments & apparatus • Maryland
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of February 19, 2013 (the “Closing Date”) by and among MIDCAP FUNDING III, LLC, a Delaware limited liability company (“MidCap”), as administrative agent (“Agent”), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), and CYTOMEDIX, INC., a Delaware corporation and the other entities shown as signatories hereto as a Borrower (collectively in the singular, “Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:
